简介:摘 要:本文通过运用杜邦分析法对净资产收益率、总资产净利率和权益乘数等各项财务指标进行分析,得出S公司的经营状况和盈利能力状况以及存在的财务问题,最后针对此问题提出可行性参考建议。
简介:摘要1例66岁男性2型糖尿病患者规律口服达格列净(10 mg、1次/d)和吡格列酮二甲双胍(515 mg、2次/d)治疗5个月余,无不良反应。患者自行将吡格列酮二甲双胍改为阿卡波糖胶囊(50 mg口服,3次/d)。3 d后患者出现全身皮肤瘙痒伴发热(体温最高41.0 ℃),随后全身出现散在黄豆至蚕豆样大小的脓疱疹,随即停用阿卡波糖胶囊。经皮肤科医师会诊,诊断为急性泛发性发疹性脓疱病。给予地塞米松抗过敏、胰岛素控制血糖和头孢西丁抗感染等治疗。停用阿卡波糖胶囊第4天,患者皮疹好转,破溃处结痂;第9天,皮疹消退。
简介: 【摘要】 目的 浅析沙库巴曲缬沙坦钠联合芪參益气滴丸治疗慢性心力衰竭(心衰)( CHF)的疗效及安全性。方法 64例 CHF患者, 采用随机数字表法分为观察组与对照组, 各 32例。观察组采取沙库巴曲缬沙坦钠联合芪参益气滴丸治疗, 对照组采取沙库巴曲缬沙坦钠治疗。比较两组患者的临床疗效、不良反应发生情况及治疗前后心率和血压变化情况、 B型脑利钠肽前体( pro-BNP)和 C反应蛋白( CRP)水平。结果 观察组治疗总有效率 96.88%高于对照组的 59.38%, 差异有统计学意义( P<0.05)。治疗后, 两组心率、舒张压、收缩压均优于治疗前, 且观察组心率、舒张压与收缩压均优于对照组, 差异有统计学意义( P<0.05)。治疗后, 两组 pro-BNP、 CRP水平均低于治疗前, 且观察组 pro-BNP( 270.38±70.83) pg/ml、 CRP( 4.04±1.02) mg/L均低于对照组的( 320.81±76.93) pg/ml、( 7.49±1.17) mg/L, 差异有统计学意义( P<0.05)。两组不良反应发生率比较差异无统计学意义( P>0.05)。结论 沙库巴曲缬沙坦钠联合芪参益气滴丸治疗 CHF的疗效乐观, 可改善心率与血压, 降低 pro-BNP、 CRP水平, 用药安全性高。 【关键词】 沙库巴曲缬沙坦钠 ;芪参益气滴丸 ;慢性心力衰竭 [Abstract] Objective To analyze the efficacy and safety of sacubatrovalsartan sodium combined with Qishen Yiqi dripping pills in the treatment of chronic heart failure (CHF). Methods 64 patients with CHF were randomly divided into observation group and control group, 32 cases in each group. The observation group was treated with shakubatrovalsartan sodium combined with Qishen Yiqi dripping pills, while the control group was treated with sacubatrovalsartan sodium. The clinical efficacy, adverse reactions, heart rate and blood pressure changes before and after treatment, and the levels of Pro BNP and CRP were compared between the two groups. Results the total effective rate of the observation group was 96.88%, which was higher than 59.38% of the control group (P < 0.05). After treatment, the heart rate, diastolic blood pressure and systolic blood pressure of the two groups were better than those before treatment, and the heart rate, diastolic blood pressure and systolic blood pressure of the observation group were better than those of the control group, the difference was statistically significant (P < 0.05). After treatment, the levels of Pro BNP and CRP in the two groups were lower than those before treatment, and the levels of Pro BNP (270.38 ± 70.83) pg / ml and CRP (4.04 ± 1.02) mg / L in the observation group were lower than those in the control group (320.81 ± 76.93) pg / ml and (7.49 ± 1.17) mg / L, and the differences were statistically significant (P < 0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P > 0.05). Conclusion the curative effect of sacubatrovalsartan sodium combined with Qishen Yiqi dripping pills in the treatment of CHF is optimistic, which can improve heart rate and blood pressure, reduce the levels of Pro BNP and CRP, and has high safety.
简介:摘要本文报告3例肾囊肿病例经CT引导下定位穿刺抽出囊液,选用无水乙醇作硬化剂,达到使囊肿收敛、缩小以至消失的效果,说明CT引导下经皮穿刺抽吸硬化剂治疗是目前非手术治疗肾囊肿的首选治疗方法。
简介:摘要目的探讨鼻内镜下低温等离子消融技术治疗126例慢性泪囊炎的效果及体会。方法应用低温等离子技术联合鼻内镜下行慢性泪囊炎治疗,临床资料分析,随访复查观察疗效。结果术后疗效标准评定,治愈113例,占89.7%,好转13例,占10.3%,总有效率100%。结论鼻内镜下低温等离子鼻腔泪囊手术,手术微创,效果良好,已成为治疗慢性泪囊炎的常用手术方法。